531762 Stock Overview
Unjha Formulations Limited manufactures and sells ayurvedic products in India.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
Unjha Formulations Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹19.42 |
| 52 Week High | ₹24.87 |
| 52 Week Low | ₹10.55 |
| Beta | 0.31 |
| 1 Month Change | 7.89% |
| 3 Month Change | 20.77% |
| 1 Year Change | 50.08% |
| 3 Year Change | 130.92% |
| 5 Year Change | 89.46% |
| Change since IPO | 68.58% |
Recent News & Updates
Recent updates
Shareholder Returns
| 531762 | IN Personal Products | IN Market | |
|---|---|---|---|
| 7D | -1.2% | 1.3% | 1.4% |
| 1Y | 50.1% | 1.7% | 46.1% |
Return vs Industry: 531762 exceeded the Indian Personal Products industry which returned 1.7% over the past year.
Return vs Market: 531762 exceeded the Indian Market which returned 46.1% over the past year.
Price Volatility
| 531762 volatility | |
|---|---|
| 531762 Average Weekly Movement | 10.0% |
| Personal Products Industry Average Movement | 4.3% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 531762's share price has been volatile over the past 3 months.
Volatility Over Time: 531762's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 17 | Kruti Patel | www.unjhaformulations.com |
Unjha Formulations Limited manufactures and sells ayurvedic products in India. The company provides sat-isabgol and isabgo husk formulation in elaichi flavor under the Anchor name; and isabgol powder in orange flavor under the Fibron and Fibron SF names, as well as natural fiber drink products. It also exports its products.
Unjha Formulations Limited Fundamentals Summary
| 531762 fundamental statistics | |
|---|---|
| Market cap | ₹87.01m |
| Earnings (TTM) | ₹2.34m |
| Revenue (TTM) | ₹169.10m |
37.1x
P/E Ratio0.5x
P/S RatioIs 531762 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 531762 income statement (TTM) | |
|---|---|
| Revenue | ₹169.10m |
| Cost of Revenue | ₹140.81m |
| Gross Profit | ₹28.30m |
| Other Expenses | ₹25.95m |
| Earnings | ₹2.34m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.52 |
| Gross Margin | 16.73% |
| Net Profit Margin | 1.39% |
| Debt/Equity Ratio | 0% |
How did 531762 perform over the long term?
See historical performance and comparison